Grace Therapeuticsの空売り状況は、投資家がGrace Therapeuticsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Grace Therapeutics (NASDAQ:GRCE) 株価情報, 空売り情報

Grace Therapeutics

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Grace Therapeutics Inc

News

Canada Lifts Suspension On Imports From Smithfield Foods Facility In Tar Heel, North Carolina, The Biggest Us Pork Plant, USDA Records Show

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. <a href="https://www.benzinga.com/quote/STRO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Matthew Hurwit downgraded Advanced Flower Capital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) from Buy to Hold and slashed the price target from $10 to $7. Advanced Flower Capital shares closed at $6.76 on Thursday. <a href="https://www.benzinga.com/quote/AFCG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Chris O&#8217;Cull downgraded Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) from Buy to Hold and lowered the price target from $20 to $12. Xponential Fitness shares closed at $12.12 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Michael Rollins downgraded the rating for T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) from Buy to Neutral and announced a $268 price target. T-Mobile US shares closed at $259.10 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying STRO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14083912/image-125-1024x583.png" alt="" class="wp-image-824738" style="width:553px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14083912/image-125-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14083912/image-125-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14083912/image-125-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14083912/image-125.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44324575/top-3-industrials-stocks-that-may-rocket-higher-this-month">Top 3 Industrials Stocks That May Rocket Higher This Month</a></li>
</ul>

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

AFCG

PTON

RVLV

STRO

TMUS

XPOF

This T-Mobile Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Wells Fargo analyst Hanwen Chang initiates coverage on Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight rating and announces Price Target of $51.

Price Target

Initiation

VNOM

Wells Fargo Initiates Coverage On Viper Energy with Overweight Rating, Announces Price Target of $51

Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>)(TSX:<a class="ticker" href="https://www.benzinga.com/stock/BHC#TSX">BHC</a>), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, today provided an update on its financing plans. The Company announced that it has engaged J.P. Morgan in connection with the Company's previously announced financing objectives.
Any transactions would be subject to market and other conditions and there can be no assurance that the Company will be able to successfully complete any transaction on acceptable terms or at all.

TSX:BHC

Bausch Health Announces That It Has Engaged J.P. Morgan In Connection With The Company's Previously Announced Financing Objectives

Financing

LAES

SEALSQ Expands Quantum-Safe Strategy With SEALQUANTUM.com Initiative And Up To $20M Investments in Quantum & AI Startups

B. Riley Securities analyst Jeff Van Sinderen maintains Xponential Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) with a Neutral and lowers the price target from $12 to $9.

B. Riley Securities Maintains Neutral on Xponential Fitness, Lowers Price Target to $9

Wells Fargo analyst Andrew Nowinski upgrades Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) from Equal-Weight to Overweight and raises the price target from $200 to $280.

Upgrades

CHKP

Wells Fargo Upgrades Check Point Software to Overweight, Raises Price Target to $280

B. Riley Securities analyst Anna Glaessgen maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Neutral and lowers the price target from $430 to $330.

ULTA

B. Riley Securities Maintains Neutral on Ulta Beauty, Lowers Price Target to $330

Dividends

FBNC

First Bancorp Announces Cash Dividend Of $0.22/Share

B. Riley Securities analyst Craig Ellis maintains D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and raises the price target from $11 to $12.

QBTS

B. Riley Securities Maintains Buy on D-Wave Quantum, Raises Price Target to $12

B. Riley Securities analyst Zach Cummings maintains FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) with a Buy and lowers the price target from $1.75 to $1.5.

NOTE

B. Riley Securities Maintains Buy on FiscalNote Holdings, Lowers Price Target to $1.5

Contracts

European Aeronautic Defence And Space Unsponsored

EADSY

VUZI

Vuzix Subsidiary Moviynt Wins Smart Glasses Deployment Commitment From Airbus Helicopters; Terms Not Disclosed

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>GLD</li>
<li>WAR</li>
<li>AAPL</li>
<li>X</li>
<li>MSTR</li>
<li>GOOGL</li>
<li>LUNR</li>
<li>INTC</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

GOOGL

INTC

LUNR

MSTR

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of March 14, 2025 (Via Swaggy Stocks)

UBS analyst David Dai upgrades Nuvalent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) from Neutral to Buy and maintains the price target from $100 to $100.

NUVL

UBS Upgrades Nuvalent to Buy, Maintains Price Target to $100

Sen. Mark Kelly (D-AZ) dismissed Elon Musk&#8217;s recent attack on him, calling the billionaire &#8220;not a serious guy&#8221; and suggesting his only allegiance is to &#8220;billionaires like himself.&#8221;
The former Navy combat pilot and astronaut clashed with Musk after the tech mogul accused him of being a &#8220;traitor&#8221; for his support of Ukraine. Kelly had recently visited the war-torn country and voiced his commitment to ensuring any peace deal with Russia protects Ukraine&#8217;s security.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a></li>
</ul>
<h2 class="wp-block-heading">Musk Calls Kelly a &#8216;Traitor&#8217; Over Ukraine Support</h2>
Kelly shared photos and remarks about his visit, <a href="https://x.com/SenMarkKelly/status/1898872403175858375">writing</a>, &#8220;Just left Ukraine. What I saw proved to me we can't give up on the Ukrainian people. Everyone wants this war to end, but any agreement has to protect Ukraine's security and can't be a giveaway to Putin.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just left Ukraine. What I saw proved to me we can't give up on the Ukrainian people. Everyone wants this war to end, but any agreement has to protect Ukraine's security and can't be a giveaway to Putin. Let me tell you about my trip and why it's important we stand with Ukraine.&#x1f9f5; <a href="https://t.co/6kOw1tTgS6">pic.twitter.com/6kOw1tTgS6</a>
&mdash; Senator Mark Kelly (@SenMarkKelly) <a href="https://twitter.com/SenMarkKelly/status/1898872403175858375?ref_src=twsrc%5Etfw">March 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk, responding on X, the platform he owns, wrote: &#8220;You are a traitor.&#8221;
Kelly swiftly <a href="https://x.com/SenMarkKelly/status/1899155561171558505">fired</a> back: &#8220;Traitor? Elon, if you don't understand that defending freedom is a basic tenet of what makes America great and keeps us safe, maybe you should leave it to those of us who do.&#8221;
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a>
<h2 class="wp-block-heading">&#8216;He's Not a Serious Guy&#8217;</h2>
Speaking to reporters in Washington on Monday, Kelly dismissed Musk's remarks. &#8220;Obviously, he&#8217;s not a serious guy,&#8221; Kelly <a href="https://x.com/DailyCaller/status/1899456338125570449">said</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f6a8; Sen. Mark Kelly Fires Back at Elon Musk &#x1f6a8; &quot;Obviously, he&#39;s not a serious guy. He&#39;s like a 12-year-old&#8211;so I don&#39;t take him seriously.&quot; <a href="https://t.co/qm3gojAWHR">pic.twitter.com/qm3gojAWHR</a>
&mdash; Daily Caller (@DailyCaller) <a href="https://twitter.com/DailyCaller/status/1899456338125570449?ref_src=twsrc%5Etfw">March 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Kelly also took aim at Musk's influence over government decisions, accusing him of slashing budgets to benefit billionaires at the expense of public service. &#8220;He&#8217;s like a 12-year-old. So I don&#8217;t take him seriously. I served our country in the Navy for 25 years. When I was 22 years old, I swore an oath to defend the Constitution. I&#8217;ve lived that oath my entire life. I&#8217;m not sure if Elon has sworn an oath to anything. If I was to guess, probably to billionaires like himself.&#8221;
Kelly also criticized Musk on MSNBC for firing veterans from his companies despite their strong performance. &#8220;The only oath I can think of that maybe Elon has sworn is an oath to his own checking account, to his pocketbook, an oath maybe to ruining the lives of veterans. I had veterans in my office last week who, after really good performance reports, found out that Elon Musk fired them for poor performance. He was ruining these people's lives … they did not deserve to get fired by an email from an unelected billionaire.&#8221;
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">Musk's History With Ukraine</h2>
Musk has been criticized in the past for his stance on Ukraine. In 2023, he reportedly blocked a Ukrainian military operation against Russia's navy by refusing to activate his Starlink satellite system in Crimea. In 2022, he suggested in a Twitter <a href="https://x.com/elonmusk/status/1576969255031296000">poll</a> that Ukraine should allow Russia to take Crimea as part of a peace deal.
Kelly&#8217;s visit to Ukraine came amid growing concerns over President Donald Trump's approach to the war. Trump has suspended military aid, criticized Ukrainian President Volodymyr Zelenskyy, and pushed for negotiations that exclude Ukraine. Kelly said he spoke to a wounded Ukrainian soldier about the shift in U.S. policy and received a blunt response: &#8220;What the f&#x2A;&#x2A;&#x2A;?&#8221;
<h2 class="wp-block-heading">Bernie Sanders Condemns Musk's Attack</h2>
Musk&#8217;s remarks drew backlash from lawmakers, including Sen. Bernie Sanders (I-VT). &#8220;It is really unspeakable. It really is. I think the American people are sick and tired of the wealthiest guy in the world running the United States government and calling, in this case, a guy who put his life on the line to defend us, a traitor. That's beyond the pale,&#8221; Sanders told CNN.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/overplay">Mark Cuban Backs This Innovative Startup That Turns Videos into Games  &#8212; Claim Your Share Now</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

'Elon Musk Isn't A Serious Guy,' Says Sen. Mark Kelly—Suggests He's Only Loyal Is To 'Billionaires Like Himself,' Not The Public

B. Riley Securities analyst Ryan Pfingst maintains Montauk Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) with a Neutral and lowers the price target from $4 to $3.

MNTK

B. Riley Securities Maintains Neutral on Montauk Renewables, Lowers Price Target to $3

Thermo Fisher Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) short percent of float has risen 7.84% since its last report. The company recently reported that it has 4.15 million shares sold short, which is 1.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Thermo Fisher Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741958126_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Thermo Fisher Scientific has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Thermo Fisher Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Thermo Fisher Scientific's peer group average for short interest as a percentage of float is 6.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is the Market Bullish or Bearish on Thermo Fisher Scientific?

Upstart Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NYSE">UPST</a>) short percent of float has fallen 6.13% since its last report. The company recently reported that it has 16.72 million shares sold short, which is 20.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Upstart Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741958121_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Upstart Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Upstart Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Upstart Hldgs's peer group average for short interest as a percentage of float is 6.18%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

UPST

How Is The Market Feeling About Upstart Hldgs?

Bank of America's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) short percent of float has fallen 14.88% since its last report. The company recently reported that it has 78.49 million shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.98 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Bank of America Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741958116_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bank of America has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Bank of America's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Bank of America's peer group average for short interest as a percentage of float is 1.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Bank of America?

Events

SOUN

SoundHound AI To Participate In 2025 NVIDIA GPU Technology Conference

Health Care

Press Releases

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024

Earnings

Grace Therapeutics Announces Second Fiscal Quarter 2025  Financial Results, Provides Business Update

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference

Grace Therapeutics to Participate in Upcoming Investor Events January 2025

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH

Grace Therapeutics Announces Private Placement Financing of up to $30 Million

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Comments

Grace Therapeutics

空売り

Grace Therapeutics (NASDAQ:GRCE) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル